101
|
Kim G, Cho S, Kim S, Oh M, Han J, Park S, Seo B, An S. 147 Comparison of in vivo and in vitro tests to predict the irritation potential of surfactants and cleansing formulation. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.151] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
102
|
Lee J, Lee R, Ju H, Kim G, Bae J, Choi C. 090 Narrow-band ultraviolet B phototherapy does not increase the risk of skin cancer in patients with vitiligo: A nationwide population-based retrospective cohort study. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
103
|
Kim G, Tan H, Wang L, Teo S, Jang C, Shabbir A, Yong W, So J. Acute pancreatitis after pressurized intraperitoneal aerosol chemotherapy oxaliplatin in an ongoing phase 1 study for peritoneal metastasis. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
104
|
Tan H, Kim G, Jang C, Shabbir A, Charles C, Li R, Wang L, Goh B, So J, Yong W. PIPAC paclitaxel: A systematic and peritoneal tissue pharmacokinetic study in swine. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.268] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
105
|
Kwong A, Cogan J, Hou Y, Lincoln V, Kim G, Chen Q, Woodley D, Chen M. 594 Gentamicin therapy induces functional laminin 332 and improves wound healing in junctional epidermolysis bullosa patients harboring nonsense mutations. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
106
|
Combs P, Imamura T, Stonebraker C, Bullard H, Simone P, LaBuhn C, Chung B, Ota T, Onsager D, Song T, Lammy T, Kim G, Smith B, Kalantari S, Nguyen A, Raikhelkar J, Sarswat N, Sayer G, Jeevanandam V, Uriel N. Opioid Use in LVAD Patients is Associated with Increased GI Bleed and Sepsis. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
107
|
Imamura T, Nitta D, Rodgers D, Grinstein J, Kalantari S, Smith B, Raikhelkar J, Kim G, Nguyen A, Narang N, Chung B, Ebong I, Holzhauser L, Fujino T, Juricek C, Combs P, Song T, Ota T, Jeevanandam V, Sayer G, Uriel N. Estimation of Pulmonary Capillary Wedge Pressure from the HVAD Waveform and Its Prognostic Implications. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
108
|
Uriel N, Burkhoff D, Kim G, Silverstein T, Raikhelkar J, Smith B, Juricek C, Jeevanandam V, Lang R, Sayer G. Oral Milrinone for the Treatment of Right Ventricular Failure in LVAD Patients. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
109
|
Gonzales E, Sayer G, Kim G, Sarswat N, Smith B, Kalantari S, Raikhelkar J, Stonebraker C, Song T, Ota T, Uriel N, LaBuhn C, Combs P, Onsager D, Jeevanandam V. Is it Possible to Implant and Manage Patients with Durable LVADs Who Refuse Blood Products? J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
110
|
Chung B, Grinstein J, Weatherford S, Tayazime S, Rodgers D, Nguyen A, Narang N, Kim G, Raikhelkar J, Jorde U, LaBuhn C, Jeevanandam V, Sayer G, Uriel N. Functional Status, Quality of Life and Ventricular Tachyarrhythmias Improve with Right Ventricular Pacing Compared to Biventricular Pacing in LVAD Patients. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
111
|
Nitta D, Imamura T, Chung B, Nguyen A, Raikhelkar J, Sarswat N, Lourenco L, Smith B, Holzhauser L, Kim G, Ebong I, Fujino T, Narang N, Murks C, Riley T, Powers J, Jeevanandam V, Sayer G, Uriel N. Correlation of ImmuKnow Assay Levels with Rejection and Infection after Heart Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.539] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
112
|
Nitta D, Imamura T, Fujino T, Rodgers D, Nguyen A, Holzhauser L, Ebong I, Narang N, Chung B, Song T, Ota T, Juricek C, Jeevanandam V, Raikhelkar J, Kim G, Sayer G, Uriel N. Lower Pulmonary Artery Pulsatility Index after Left Ventricular Assist Device Implantation is Associated with Worse Heart Failure Free Survival. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
113
|
Lourenco L, Lang K, Simone P, Patel S, Powers J, Riley T, Murks C, Smith B, Kalantari S, Raikhelkar J, Sarswat N, Kim G, Sayer G, Uriel N. Association between Cumulative Pre-Transplant Amiodarone Dose and Post-Transplant Outcomes after Heart Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
114
|
Imamura T, Raikhelkar J, Kim G, Smith B, Kalantari S, Nguyen A, Narang N, Chung B, Ebong I, Holzhauser L, Grinstein J, Nitta D, Fujino T, Juricek C, Rodgers D, Combs P, Song T, Ota T, Jeevanandam V, Sayer G, Uriel N. Aortic Insufficiency is Associated with Hemocompatibility-Related Adverse Events in LVAD Patients. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
115
|
Smith B, Parker W, Kalantari S, Raikhelkar J, Kim G, Sarswat N, Sayer G, Nguyen A, Chung B, Holzhauser L, Narang N, Ebong I, Rich J, Anderson A, Uriel N, Vorovich E. Effect of Recipient Race on Quality of Donors Allocated to Heart Transplant Recipients. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
116
|
Symalla T, Song T, Onsager D, Ota T, LaBuhn C, Combs P, Lammy T, Patel-Raman S, Sayer G, Kim G, Raikhelkar J, Uriel N, Jeevanandam V. Hemodynamic Parameters That Predict Success with an Ambulatory Counterpulsation Heart Assist System in Advanced Congestive Heart Failure. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
117
|
Koda Y, Kitahara H, Kim G, Sarswat N, Kalantari S, Smith B, Raikhelkar J, Sayer G, Onsager D, Song T, Uriel N, Jeevanandam V, Ota T. Surgical Device Exchange is Favorable to Treat Device Thrombosis Compared to Medical Therapy. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
118
|
Belkin M, Imamura T, Kanelidis A, Holzhauser L, Ebong I, Narang N, Blair J, Nathan S, Paul J, Shah A, Chung B, Nguyen A, Smith B, Kalantari S, Raikhelkar J, Sarswat N, Kim G, Sayer G, Uriel N. TAVI in LVAD Patients with Aortic Insufficiency. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.162] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
119
|
Imamura T, Smith B, Raikhelkar J, Rodgers D, Kim G, Kalantari S, Nguyen A, Narang N, Chung B, Ebong I, Holzhauser L, Nitta D, Fujino T, Juricek C, Combs P, Onsager D, Song T, Ota T, Jeevanandam V, Sayer G, Uriel N. Right Heart Function Worsens in LVAD Patients with Decoupling between Pulmonary Artery and Wedge Pressures. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
120
|
Imamura T, Nguyen A, Nitta D, Rodgers D, Kalantari S, Smith B, Raikhelkar J, Narang N, Chung B, Ebong I, Holzhauser L, Fujino T, Juricek C, Combs P, Onsager D, Song T, Ota T, Jeevanandam V, Kim G, Sayer G, Uriel N. Worsening of Right Heart Function Following Left Ventricular Assist Device Implantation - Right Heart Catheter Waveform Analyses. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
121
|
Weigt S, Kim G, Abtin F, Jones H, Shino Y, DerHovanessian A, Sayah D, Saggar R, Lynch J, Belperio J, Ross D, Goldin J. CLAD Phenotypes Determined by Change in Spirometric Index Associate with Quantitative Image Analyses. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.549] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
122
|
Han K, Kim M, Lee D, Won J, Kim G, Kwon J, Han S, Kim D, Kim H, Baek S, Lee J. 03:09 PM Abstract No. 412 Safety of co-placement of ventriculoperitoneal shunt and percutaneous radiologic gastrostomy. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
123
|
Kwon J, Han K, Lee J, Won J, Kim M, Kim G, Lee D, Han S, Baek S. Abstract No. 510 Safety and efficacy of percutaneous cryoablation for small hepatocellular carcinomas adjacent to the heart. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
124
|
Meade D, Hensley Alford S, Mahatma S, Malangone-Monaco E, Boulanger L, Tkacz J, Turner SJ, Chen S, Manson S, Mejia S, Buleje I, Madan P, Kim G, Fowler R, Basar A. Abstract P4-09-06: Analyzing the changes in the HR+/HER2- metastatic breast cancer (mBC) landscape since the arrival of CDK4/6 inhibitors with machine learning and visual analytics. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-09-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: The real-world impact of CDK4/6 inhibitor use on HR+/HER2- mBC treatment sequencing, treatment response, and therapeutic utilization is limited. This study sought to describe treatment sequencing and response pre- and post-FDA approval of CDK4/6 inhibitors by conducting a traditional observational study approach and supplementing with a machine-learning methodology.
METHODS: Female patients ≥18yrs were identified in the MarketScan Commercial and Medicare Supplement databases with continuous enrollment for at least 12 months pre-index, ≥2 medical claims for a BC diagnosis and ≥2 medical claims for metastatic disease (earliest=index date), and who had no treatment at any time with HER2 targeted therapy. Patients were excluded if they had received CDK4/6 or everolimus treatment prior to index. Treatment was stratified by line of therapy pre- and post- first CDK4/6 approval (February 3, 2015). We identified treatment patterns with standard distributions and visual analytics. Response to therapy and utilization was analyzed with prediction models and IBM Watson® machine learning population comparison models.
RESULTS: A total of 19,558 patients were eligible for the study with a mean age at diagnosis of mBC of 62 (SD 13). Prior to first CDK4/6 inhibitor approval, anastrazole and letrozole monotherapies were most likely to be identified as both first and second line treatment. Following approval of the first CDK4/6 inhibitor in 2015, CDK4/6 inhibitors were observed as a first line treatment in 25% of patients, and as second line treatment in 24% of patients. Of patients diagnosed following the first CDK4/6 inhibitor approval, 44% of patients were exposed to endocrine therapy and 10% were exposed to chemotherapy in the pre-index period. Patients receiving CDK4/6 inhibitors in combination with endocrine therapy as first line treatment were observed to have a longer progression free survival time than patients receiving endocrine monotherapy. Visual analytics demonstrate a large variation in treatment sequencing, especially after first line therapy. Machine learning and prediction models identified a strong secular bias in the use of CDK4/6 and a signal for improved treatment response in patients with no exposure to endocrine therapies in the pre-index period.
CONCLUSIONS: The mBC treatment landscape has changed significantly with the introduction of CDK4/6 inhibitors, which may be expected to impact long-term outcomes. Visual analytics and machine learning approaches can improve clinical insight. These approaches can help with identifying patient and clinical characteristics that predict response and utilization as well as appropriate treatment selections across lines of therapy.
Citation Format: Meade D, Hensley Alford S, Mahatma S, Malangone-Monaco E, Boulanger L, Tkacz J, Turner SJ, Chen S, Manson S, Mejia S, Buleje I, Madan P, Kim G, Fowler R, Basar A. Analyzing the changes in the HR+/HER2- metastatic breast cancer (mBC) landscape since the arrival of CDK4/6 inhibitors with machine learning and visual analytics [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-09-06.
Collapse
|
125
|
Chin KB, Lee C, Kim G. Evaluation of Product Quality of Low-Salt Pork Sausage Using Prerigor Pork Ham. MEAT AND MUSCLE BIOLOGY 2019. [DOI: 10.22175/mmb2019.0048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|